Evidence map›Paper›PMID 31936748›Full record

ArticleJournal of clinical medicine2020

Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS) after Polytrauma: A Rare Syndrome with Major Consequences.

Lillian Hesselink, Ruben J Hoepelman, Roy Spijkerman, Mark C H de Groot, Karlijn J P van Wessem, Leo Koenderman, Luke P H Leenen, Falco Hietbrink

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. New findings on CD16Frontiers in immunology · 2024
    Observational
  20. IL-7 producing immunotherapy improvesHuman vaccines & immunotherapeutics · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lillian HesselinkDepartment of Trauma Surgery, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Ruben J HoepelmanDepartment of Trauma Surgery, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Roy SpijkermanDepartment of Trauma Surgery, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.ORCID 0000-0002-3620-5433
Mark C H de GrootDepartment of Clinical Chemistry and Hematology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.ORCID 0000-0002-5764-5788
Karlijn J P van WessemDepartment of Trauma Surgery, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.ORCID 0000-0002-1166-0990
Leo KoendermanCenter for Translational Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.ORCID 0000-0002-5636-6453
Luke P H LeenenDepartment of Trauma Surgery, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.ORCID 0000-0001-8385-1801
Falco HietbrinkDepartment of Trauma Surgery, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nowadays, more trauma patients develop chronic critical illness (CCI), a state characterized by prolonged intensive care. Some of these CCI patients have disproportional difficulties to recover and suffer from recurrent infections, a syndrome described as the persistent inflammation, immunosuppression and catabolism syndrome (PICS). A total of 78 trauma patients with an ICU stay of ≥14 days (CCI patients) between 2007 and 2017 were retrospectively included. Within this group, PICS patients were identified through two ways: (1) their clinical course (≥3 infectious complications) and (2) by laboratory markers suggested in the literature (C-reactive protein (CRP) and lymphocytes), both in combination with evidence of increased catabolism. The incidence of PICS was 4.7 per 1000 multitrauma patients. The sensitivity and specificity of the laboratory markers was 44% and 73%, respectively. PICS patients had a longer hospital stay (median 83 vs. 40,

Indexed as

immunologyinfectious complicationsPICStrauma

Identifiers

PMID31936748
PMCPMC7019692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.